Literature DB >> 17599397

Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents.

Panayotis K Thanos1, Michael Michaelides, Helene Benveniste, Gene Jack Wang, Nora D Volkow.   

Abstract

BACKGROUND: Methylphenidate (MP) and amphetamine, which are the mainstay for the treatment of ADHD, have raised concerns because of their reinforcing effects and the fear that their chronic use during childhood or adolescence could induce changes in the brain that could facilitate drug abuse in adulthood.
METHODS: Here we measured the effects of chronic treatment (8 months) with oral MP (1 or 2 mg/kg), which was initiated in periadolescent rats (postnatal day 30). Following this treatment, rats were tested on cocaine self-administration. In addition at 2 and 8 months of treatment we measured dopamine D2 receptor (D2R) availability in the striatum using [(11)C]raclopride microPET (microPET) imaging.
RESULTS: Animals treated for 8 months with 2 mg/kg of MP showed significantly reduced rates of cocaine self-administration at adulthood than vehicle treated rats. D2R availability in the striatum was significantly lower in rats after 2 months of treatment with MP (1 and 2 mg/kg) but significantly higher after 8 months of MP treatment than in the vehicle treated rats. In vehicle treated rats D2R availability decreased with age whereas it increased in rats treated with MP. Because low D2R levels in the striatum are associated with a propensity for self-administration of drugs both in laboratory animals and in humans, this effect could underlie the lower rates of cocaine self-administration observed in the rats given 8 months of treatment with MP.
CONCLUSIONS: Eight month treatment with oral MP beginning in adolescence decreased cocaine-self administration (1 mg/kg) during adulthood which could reflect the increases in D2R availability observed at this life stage since D2R increases are associated with reduced propensity for cocaine self administration. In contrast, two month treatment with MP started also at adolescence decreased D2R availability, which could raise concern that at this life stage short treatments could possibly increase vulnerability to drug abuse during adulthood. These findings indicate that MP effects on D2R expression in the striatum are sensitive not only to length of treatment but also to the developmental stage at which treatment is given. Future studies evaluating the effects of different lengths of treatment on drug self-administration are required to assess optimal duration of treatment regimes to minimize adverse effects on the propensity for drug self administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599397     DOI: 10.1016/j.pbb.2007.05.020

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  43 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.

Authors:  Brandon L Warren; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Eric M Parise; Sarah K Weakley; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

3.  Oral methylphenidate establishes a conditioned place preference in rats.

Authors:  Thomas E Wooters; Matthew T Walton; Michael T Bardo
Journal:  Neurosci Lett       Date:  2010-10-23       Impact factor: 3.046

4.  Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.

Authors:  Britahny M Baskin; Linda P Dwoskin; Kathleen M Kantak
Journal:  Pharmacol Biochem Behav       Date:  2015-01-31       Impact factor: 3.533

5.  Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.

Authors:  Lyonna F Alcantara; Brandon L Warren; Eric M Parise; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Psychopharmacology (Berl)       Date:  2014-01-23       Impact factor: 4.530

6.  The effects of rearing environment and chronic methylphenidate administration on behavior and dopamine receptors in adolescent rats.

Authors:  Kathryn E Gill; Thomas J R Beveridge; Hilary R Smith; Linda J Porrino
Journal:  Brain Res       Date:  2013-06-24       Impact factor: 3.252

7.  Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.

Authors:  Kathryn E Gill; Peter J Pierre; James Daunais; Allyson J Bennett; Susan Martelle; H Donald Gage; James M Swanson; Michael A Nader; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

8.  Suboptimal maternal diets alter mu opioid receptor and dopamine type 1 receptor binding but exert no effect on dopamine transporters in the offspring brain.

Authors:  Panayotis K Thanos; Jianmin Zhuo; Lisa Robison; Ronald Kim; Mala Ananth; Ilon Choai; Adam Grunseich; Nicola M Grissom; Robert George; Foteini Delis; Teresa M Reyes
Journal:  Int J Dev Neurosci       Date:  2016-09-22       Impact factor: 2.457

9.  A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.

Authors:  Panayotis K Thanos; Lisa S Robison; Jessica Steier; Yu Fen Hwang; Thomas Cooper; James M Swanson; David E Komatsu; Michael Hadjiargyrou; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2015-01-29       Impact factor: 3.533

10.  Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.

Authors:  S S Somkuwar; K M Kantak; M T Bardo; L P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2015-12-02       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.